The PE ratio for Lifevantage stock stands at 69.82 as of Feb 4, 2025. The calculation is based on the latest EPS of $0.34 and the stock price of $23.74 per share. An increase of 154% has been observed in the PE ratio compared to its average of 27.5 of the past four quarters.
Over the last ten years, the average PE ratio of Lifevantage has been 23.49. The current 69.82 price-to-earnings ratio is 197% more than the historical average. Analyzing the last ten years, LFVN's PE ratio reached its highest point in the Sep 2022 quarter at 75, with a price of $3.75 and an EPS of $0.05. The Mar 2022 quarter saw the lowest point at 6.7, with a price of $4.76 and an EPS of $0.71.
Maximum annual increase: 325.17% in 2016
Maximum annual decrease: -59.44% in 2014
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 26.75 | 22.99% | $6.42 | $0.24 |
2023 | 21.75 | 19.97% | $4.35 | $0.2 |
2022 | 18.13 | 126.91% | $4.35 | $0.24 |
2021 | 7.99 | -51.55% | $7.35 | $0.92 |
2020 | 16.49 | -32.67% | $13.52 | $0.82 |
2019 | 24.49 | 57.59% | $12.98 | $0.53 |
2018 | 15.54 | -56.93% | $6.37 | $0.41 |
2017 | 36.08 | 16.73% | $4.33 | $0.12 |
2016 | 30.91 | 325.17% | $13.6 | $0.44 |
2015 | 7.27 | -45.91% | $3.71 | $0.51 |
2014 | 13.44 | -59.44% | $10.08 | $0.75 |
2013 | 33.14 | 40.54% | $16.24 | $0.49 |
2012 | 23.58 | N/A | $19.81 | $0.84 |
2011 | N/A | N/A | $10.5 | -$4.83 |
2010 | N/A | N/A | $3.57 | -$1.33 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 35.53 | 32.82% | $12.08 | $0.34 |
Jun 2024 | 26.75 | 23.79% | $6.42 | $0.24 |
Mar 2024 | 21.61 | -17.17% | $6.05 | $0.28 |
Dec 2023 | 26.09 | -19.1% | $6 | $0.23 |
Sep 2023 | 32.25 | 48.28% | $6.45 | $0.2 |
Jun 2023 | 21.75 | N/A | $4.35 | $0.2 |
Mar 2023 | N/A | N/A | $3.59 | -$0.05 |
Dec 2022 | N/A | N/A | $3.72 | -$0.04 |
Sep 2022 | 75 | 313.68% | $3.75 | $0.05 |
Jun 2022 | 18.13 | 170.6% | $4.35 | $0.24 |
Mar 2022 | 6.7 | -21.55% | $4.76 | $0.71 |
Dec 2021 | 8.54 | 26.14% | $6.32 | $0.74 |
Sep 2021 | 6.77 | -15.27% | $6.77 | $1 |
Jun 2021 | 7.99 | -29.1% | $7.35 | $0.92 |
Mar 2021 | 11.27 | 0.36% | $9.35 | $0.83 |
Currently, LFVN's PE ratio is higher than the 3, 5 and 10-year averages.
LFVN's PE ratio is above its peer stocks USNA and NATR.
Stock name | PE ratio | Market cap |
---|---|---|
USNA Usana Health Sciences Inc | 11.12 | $601.71M |
NATR Natures Sunshine Products Inc | 16.09 | $261.61M |
LFVN Lifevantage Corp | 69.82 | $297.35M |
OGEN Oragenics Inc | N/A | $3.47M |
MTEX Mannatech Inc | N/A | $22.58M |
As of Feb 4, 2025, LFVN stock has a price to earnings ratio of 69.82.
As an average over the last 3 years, LFVN stock has a PE ratio of 29.31.
As an average over the last 5 years, LFVN stock has a PE ratio of 20.72.
Over the last ten years, the quarterly PE ratio reached its highest level at 75 in the Sep 2022 quarter.
LFVN's current price to earnings ratio is 197% above its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Feb 4, 2025), Lifevantage's share price is $23.74. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.34. Therefore, Lifevantage's price to earnings ratio for today is 69.82. PE RATIO(69.82) = STOCK PRICE($23.74) / TTM EPS($0.34)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.